Gowling WLG advised Sosei Heptares on an agreement with new company Tempero Bio to advance treatments in neurological diseases. The arrangement will provide Tempero Bio with…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
